Download PDF
Neurologie up2date 2022; 05(01): 73-96
DOI: 10.1055/a-1514-2141
Myopathien und Neuropathien

Mitochondriale Erkrankungen – Ein Update zu Klinik, Diagnostik und Therapie

Claudia Stendel
1   Friedrich-Baur-Institut, Neurologischen Klinik und Poliklinik der LMU München, München, Deutschland
,
Christiane Michaela Neuhofer
2   Friedrich-Baur-Institut, Neurologischen Klinik und Poliklinik der LMU München, München, Deutschland
,
Thomas Klopstock
3   Friedrich-Baur-Institut, Neurologischen Klinik und Poliklinik der LMU München, München, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Mitochondriale Erkrankungen sind genetisch und klinisch sehr heterogene Krankheitsbilder und gehören zu den häufigsten hereditären Erkrankungen. Aufgrund der Mannigfaltigkeit der Symptome ist der Weg zur korrekten Diagnose oft erschwert und zeitverzögert. In dieser Übersicht werden die typischen Symptome und klassischen Krankheitsbilder sowie aktuelle Therapieoptionen zusammengefasst.

Publication History

Article published online:
09 March 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Sperl W, Freisinger P. Mitochondriopathien. et al. In: Hoffmann G, Lentze M, Spranger J. Pädiatrie. Springer, Berlin, Heidelberg: Springer Reference Medizin; 2019
    Search in Google Scholar
  • 2 GENOMIT. Disease Genes. https://genomit.eu/work-packages/integrated-diagnostics/disease-genes/index.html
  • 3 Munnich A, Rötig A, Chretien D. et al. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 1996; 155: 262-274
    CrossrefPubMedSearch in Google Scholar
  • 4 Klopstock T, Priglinger C, Yilmaz A. et al. Mitochondriale Erkrankungen. Dtsch Arztebl Int 2021; 118: 741-748
    CrossrefPubMedSearch in Google Scholar
  • 5 Footitt EJ, Sinha MD, Raiman JA. et al. Mitochondrial disorders and general anaesthesia: a case series and review. Br J Anaesth 2008; 100: 436-441
    CrossrefPubMedSearch in Google Scholar
  • 6 Chiaratta MR, Meirelles FV, Wells D. et al. Therapeutic treatments of mtDNA diseases at the earliest stages of human development. Mitochondrion 2011; 11: 820-828
    CrossrefPubMedSearch in Google Scholar
  • 7 Poulton J, Steffann J, Burgstaller J. et al. 234th ENMC international workshop: Developing guidelines for management of reproductive options for families with maternally inherited mtDNA disease; Amsterdam, the Netherlands, 22–24 March 2019. Neuromuscul Disord 2019; 29: 725-733
    CrossrefPubMedSearch in Google Scholar
  • 8 Pickett SJ, Blain A, Ng YS. et al. Mitochondrial donation – which woman could benefit?. N Engl J Med 2019; 380: 1971-1972
    CrossrefPubMedSearch in Google Scholar
  • 9 Schaefer AM, Mcfarland R, Blakely EL. et al. Prevalence of mitochondrial DNA diseas in adults. Ann Neurol 2008; 63: 35-39
    CrossrefPubMedSearch in Google Scholar
  • 10 Rabenstein R, Catarino C, Rampeltshammer V. et al. Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber`s Hereditary Optic Neuropathy mutation carriers: a prospective cohort study. Orphanet J Rare Dis 2021; 16: 127
    CrossrefPubMedSearch in Google Scholar
  • 11 Klopstock T, Yu-Wai-Man P, Dimitriadis K. et al. A randomized placebo-controlled trial of idebenone in Leberʼs hereditary optic neuropathy. Brain 2011; 134: 2677-2686
    CrossrefPubMedSearch in Google Scholar
  • 12 Catarino CB, von Livonius B, Priglinger C. et al. Real-world clinical experience with Idebenone in the treatment of Leber Hereditary Optic Neuropathy. J Neuroophthalmol 2020; 40: 558-565
    CrossrefPubMedSearch in Google Scholar
  • 13 Carelli V, Carbonelli M, De Coo IF. et al. International consensus statement on the clinical and therapeutic management of Leber Hereditary Optic Neuropathy. J Neuroophthalmol 2017; 37: 371-381
    CrossrefPubMedSearch in Google Scholar
  • 14 Yu-Wai-Man P, Newman NJ, Carelli V. et al. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med 2020; 12: eaaz7423
    CrossrefPubMedSearch in Google Scholar
  • 15 Newmann NJ, Yu-Wai-Man P, Carelli V. et al. Efficacy and safety of intravitreal gene therapy for Leber Hereditary Optic Neuropathy treated within 6 months of disease onset. Ophthalmology 2021; 128: 649-660
    CrossrefPubMedSearch in Google Scholar
  • 16 Holt IJ, Cooper JM, Morgan-Hughes JA. et al. Deletions of muscle mitochondrial DNA. Lancet 1988; 1: 1-462
    CrossrefPubMedSearch in Google Scholar
  • 17 Chinnery PF, DiMauroSShanske S. et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004; 364: 592-596
    CrossrefPubMedSearch in Google Scholar
  • 18 Deschauer M, Zierz S. Defekte der intergenomischen Kommunikation: Mutationen der Kern-DNA und multiple Deletionen der mitochondrialen DNA bei chronisch progressive externer Opthalmoplegie. Akt Neurol 2002; 30: 103-106
    Thieme ConnectSearch in Google Scholar
  • 19 Fratter C, Raman P, Alston CL. et al. RRM2B mutations are frequent in familial PEO with multiple DNA deletions. Neurology 2011; 76: 2032-2034
    CrossrefPubMedSearch in Google Scholar
  • 20 Ahn J, Kim NJ, Choung HK. et al. Frontalis sling operation using silicone rod for the correction of ptosis in chronic progressive external opthalmoplegia. Br J Ophthalmol 2008; 92: 1685-1688
    CrossrefPubMedSearch in Google Scholar
  • 21 Moraes CT, DiMauro S, Zeviani M. et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre-Syndrome. N Engl F Med 1989; 320: 1293-1299
    CrossrefPubMedSearch in Google Scholar
  • 22 Pineda M, Ormazábal A, López-Gallardo E. et al. Cerebral folate deficiency and leukoencephalopathy caused by mitochondrial DNA deletion. Ann Neurol 2006; 59: 394-398
    CrossrefPubMedSearch in Google Scholar
  • 23 Ciafaloni E, Ricci E, Shanske S. et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-398
    CrossrefPubMedSearch in Google Scholar
  • 24 Lam CW, Lau CH, William JC. et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 1997; 156: 562-564
    CrossrefPubMedSearch in Google Scholar
  • 25 Silvestri G, Ciafaloni E, Santorelli FM. et al. Clinical features associated with the A-- >G transition at nucleotide 8344 of mtDNA (“MERRF mutation). Neurology 1993; 43: 1 200-1206
    CrossrefPubMedSearch in Google Scholar
  • 26 Shoffner JM, Lott MT Lezza AM. et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61: 931-937
    CrossrefPubMedSearch in Google Scholar
  • 27 Orsucci D, Ienco EC, Siciliano G. et al. Mitochondrial disorders and drugs: what every physician should know. Drugs Context 2019; 8: 212588
    CrossrefPubMedSearch in Google Scholar
  • 28 Holt U, Harding AE, Petty RHK. et al. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990; 46: 428-433
    PubMedSearch in Google Scholar
  • 29 Stendel C, Neuhofer C, Floride E. et al. Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration. Neurol Genet 2020; 6: e393
    CrossrefPubMedSearch in Google Scholar
  • 30 Lake NJ, Compton AG, Rahman S. et al. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol 2016; 79: 190-203
    CrossrefPubMedSearch in Google Scholar
  • 31 Hirano M, Silvestri G, Blake DM. et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-727
    CrossrefPubMedSearch in Google Scholar
  • 32 Yavuz H, Ozel A, Christensen M. et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007; 64: 435-8
    CrossrefPubMedSearch in Google Scholar
  • 33 Lara MC, Weiss B, Illa I. et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006; 67: 1461-3
    CrossrefPubMedSearch in Google Scholar
  • 34 Halter J, Schüpfbach WM, Mandel H. et al. Allogenic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain 2015; 138: 2847-2858
    CrossrefPubMedSearch in Google Scholar
  • 35 Halter J, Schüpfbach WM, Casali C. et al. Allogenic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011; 463: 330-337
    CrossrefPubMedSearch in Google Scholar
  • 36 Bax BE, Levene M, Main MD. et al. Erythrocyte encapsulated thymidine phosphorylase for the treatment of patients with mitochondrial neurogastrointestinal encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial. J Clin Med 2019; 8: 1096
    CrossrefPubMedSearch in Google Scholar
  • 37 DʼAngelo R, Boschetti E, Amore G. et al. Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications. J Neurol 2020;
    CrossrefPubMedSearch in Google Scholar
  • 38 Gempel K, Topaloglu H, Talim B. et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron transferring flavoprotein dehydrogenase (ETFDH) gene. Brain 2007; 130: 2017-2044
    CrossrefPubMedSearch in Google Scholar
  • 39 Swalwell H, Deschauer M, Hartl H. et al. Pure myopathy associated with a novel mitochondrial tRNA gene mutation. Neurology 2006; 66: 447-449
    CrossrefPubMedSearch in Google Scholar
  • 40 Horvath R, Hudson G, Ferrari G. et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 2006; 129: 1674-1684
    CrossrefPubMedSearch in Google Scholar
  • 41 Rodriguez MC, MacDonald JR, Mahoney DJ. et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerv 2007; 35: 235-242
    CrossrefPubMedSearch in Google Scholar
  • 42 Gorman GS, Chinnery PF, DiMauro S. et al. Mitochondrial diseases. Nat Rev Dis Primers 2016; 2: 16080
    CrossrefPubMedSearch in Google Scholar
  • 43 Desbats MA, Lunardi G, Doimo M. et al. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency. J Inherit Metab Dis 2015; 38: 145-156
    CrossrefPubMedSearch in Google Scholar